Identification of gestational diabetes mellitus in European electronic healthcare databases: insights from the ConcePTION project
In this multinational study, GDM prevalence ranged from 1.3% to 15.8% depending on the algorithm and database. Nordic countries showed smaller differences in prevalence between algorithms, while the other countries showed larger variations, likely due to differences in coding practices, healthcare systems and database coverage.
Authors
- Constanza L. Andaur Navarro (ORCID: https://orcid.org/0000-0002-7745-2887)
- Laura García‐Villodre (ORCID: https://orcid.org/0000-0001-9094-7107)
- Ditte Mølgaard‐Nielsen (ORCID: https://orcid.org/0000-0003-4813-4289)
- Laia Barrachina‐Bonet (ORCID: https://orcid.org/0000-0002-5272-265X)
- Joan K. Morris (ORCID: https://orcid.org/0000-0002-7164-612X)
- Clara Cavero‐Carbonell (ORCID: https://orcid.org/0000-0002-4858-6456)
- Marleen M. H. J. van Gelder (ORCID: https://orcid.org/0000-0003-4853-4434)
- Sandra López‐León (ORCID: https://orcid.org/0000-0001-7504-3441)
- Saeed Hayati (ORCID: https://orcid.org/0000-0003-4650-6413)
- Marco Manfrini (ORCID: https://orcid.org/0000-0003-3154-9269)
- Vera Ruth Mitter (ORCID: https://orcid.org/0000-0002-1483-5020)
- Angela Lupattelli (ORCID: https://orcid.org/0000-0002-8787-3183)
- Vjola Hoxhaj (ORCID: https://orcid.org/0009-0007-2194-0818)
- Maarit K. Leinonen (ORCID: https://orcid.org/0000-0002-7631-4749)
- Hedvig Nordeng (ORCID: https://orcid.org/0000-0001-6361-2918)
- Sue Jordan (ORCID: https://orcid.org/0000-0002-5691-2987)
- Visa Martikainen
- Anthony Caillet
- Christine Damase‐Michel
- A.A. Geldof
- Amanda J. Neville
- Marie Beslay (ORCID: https://orcid.org/0000-0002-5153-1747)
- Luca Cammarota
Institutions
- Rutgers, The State University of New Jersey (US)
- University of London (GB)
- Bern University of Applied Sciences (CH)
- Université Fédérale de Toulouse Midi-Pyrénées (FR)
- University of Oslo (NO)
- Novo Nordisk (Denmark) (DK)
- Utrecht University (NL)
- University of Ferrara (IT)
- Swansea University (GB)
- Finnish Institute for Health and Welfare (FI)
- Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (ES)
- Janssen (Netherlands) (NL)
- Tris Pharma (United States) (US)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1136/bmjopen-2025-102343
- Primary Topic
- Gestational Diabetes Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Federation of Pharmaceutical Industries and Associations
- European Commission
- Regione Emilia-Romagna